{"id":796,"date":"2024-10-22T18:53:50","date_gmt":"2024-10-22T18:53:50","guid":{"rendered":"http:\/\/eurosoi.org\/?p=796"},"modified":"2024-10-22T18:53:50","modified_gmt":"2024-10-22T18:53:50","slug":"the-error-bar-indicates-the-standard-deviation-from-3-technical-repetitions","status":"publish","type":"post","link":"https:\/\/eurosoi.org\/?p=796","title":{"rendered":"\ufeffThe error bar indicates the standard deviation from 3 technical repetitions"},"content":{"rendered":"

\ufeffThe error bar indicates the standard deviation from 3 technical repetitions. three times with similar results.(TIF) ppat.1008475.s002.tif (2.1M) GUID:?E0985CE3-FC95-427E-94CA-FC6943BB8976 S2 Fig: Self-association of Tm-22 domains. Fusion proteins with C-terminally HA or Myc tag were used to perform co-IP assays. All samples were subjected to IP with anti-Myc beads. (A) Tm-22 CC-HA was not immunoprecipitated by Tm-22 CC-Myc, but RPM1 CC-HA interacted with RPM1 CC-Myc in the same condition. (B) Tm-22 NB-ARC-HA was immunoprecipitated by Tm-22 NB-ARC-Myc. (C) Tm-22 LRR-HA was immunoprecipitated by Tm-22 LRR-Myc relative to empty control.(TIF) ppat.1008475.s003.tif (717K) GUID:?7CD52140-ACD0-4CBD-9820-248167B1B700 S3 Fig: Fractionation of CC, NB-ARC and LRR fused to Rop or mRop motif. Cell lysates were separated to the soluble and microsomal membrane fractionations. T, total protein; S, soluble fraction; M, microsomal membrane fraction. H+-ATPase is the PM marker detected by IB, and RbcL is the soluble protein marker detected by Ponceau S.(TIF) ppat.1008475.s004.tif (362K) GUID:?FF9313BD-E095-4AFF-83F7-7E6D4480A142 S4 Fig: Western blot of Rop or mRop fusion proteins. (A) Fusion proteins were probed with anti-Myc antibody. (B) Fusion proteins were probed with anti-GFP antibody.(TIF) ppat.1008475.s005.tif (337K) GUID:?4D4E8962-70F2-47D7-903A-B8A5B7E74B38 S5 Fig: Subcellular localization and expression level of YFP-Rop fusion proteins. (A) Confocal images AGN 195183<\/a> showed YFP-Rop successfully tethered fusion proteins to the PM. (B) Protein levels were detected by anti-GFP antibody.(TIF) ppat.1008475.s006.tif (2.5M) GUID:?3F93F2AF-D7DF-4574-88D5-28DA70D7F97F S6 Fig: Importance of R291 in CC-NB-ARC (D481V)-Rop. (A) R291A mutation inhibited cell death mediated by CC-NB-ARC (D481V)-Myc-Rop. Pictures were taken at 3 dpi. (B) R291A disrupted the self-association of CC-NB-ARC (D481V)-Rop. All samples were subjected to IP with anti-GFP beads.(TIF) AGN 195183 ppat.1008475.s007.tif (1.1M) GUID:?E2A9F211-D555-479D-AECF-CCFF7A8E40E0 S7 Fig: K191R and R291A disrupted AGN 195183 the self-association of NB-ARC (D481V). Co-IP assay showed that both K191R and R291A disrupted the self-association of NB-ARC (D481V). All samples were subjected to IP with anti-Myc beads.(TIF) ppat.1008475.s008.tif (259K) GUID:?CD24188E-4A5B-4566-BBF8-01AF79353659 S8 Fig: L233A, L242A and L246A disturbed the cell death phenotype and self-association of CC-NB-ARC (D481V)-Rop. (A) Trypan blue staining showed that L233A, L242A and L246A disturbed the cell death phenotype induced by CC-NB-ARC (D481V)-Myc-Rop. (B) The expression of CC-NB-ARC-Myc-Rop and its mutants were detected by anti-Myc antibody. RbcL was stained by Ponceau S as loading control. (C) Co-IP assay showed that L233A, L242A Rabbit polyclonal to Fyn.Fyn a tyrosine kinase of the Src family.Implicated in the control of cell growth.Plays a role in the regulation of intracellular calcium levels.Required in brain development and mature brain function with important roles in the regulation of axon growth, axon guidance, and neurite extension.Blocks axon outgrowth and attraction induced by NTN1 by phosphorylating its receptor DDC.Associates with the p85 subunit of phosphatidylinositol 3-kinase and interacts with the fyn-binding protein.Three alternatively spliced isoforms have been described.Isoform 2 shows a greater ability to mobilize cytoplasmic calcium than isoform 1.Induced expression aids in cellular transformation and xenograft metastasis.<\/a> and L246A disturbed the self-association of CC-NB-ARC (D481V)-Rop. All samples were subjected to IP with anti-GFP beads.(TIF) ppat.1008475.s009.tif (2.7M) GUID:?D29592A6-E712-4766-9CAB-B520C8882CAF Data Availability StatementAll sequence files are available from the Genbank\/EMBL database (accession number(s) Tm-22 (AAQ10736.1), TMV MP (BAF93925.1), AtRop10 (OAP04715.1), RPM1 (AGC12590.1).). Abstract The nucleotide-binding, leucine-rich repeat-containing (NLR) class of immune receptors of plants and animals recognize pathogen-encoded proteins and trigger host defenses. Although animal NLRs form oligomers upon pathogen recognition to activate downstream signaling, the mechanisms of herb NLR activation remain largely elusive. Tm-22 is usually a plasma membrane (PM)-localized coiled coil (CC)-type NLR and confers resistance to (TMV) by recognizing its viral movement protein (MP). In this study, we found that Tm-22 self-associates upon recognition of MP. The CC domain name of Tm-22 is the signaling domain name and its function requires PM localization and self-association. The nucleotide-binding (NB-ARC) domain name is important for Tm-22 self-interaction and regulates activation of the CC domain name through its nucleotide-binding and self-association. (d)ATP binding may alter the NB-ARC conformation to release its suppression of Tm-22 CC domain-mediated cell death. Our findings provide the first example of signaling domain name for PM-localized NLR and insight into PM-localized NLR activation. Author summary Nucleotide-binding, leucine-rich repeat proteins (NLR) can function as immune receptors of plants and animals and confer resistance against pathogens. However, despite their importance in immunity, the activation mechanism of PM-localized NLRs remains largely elusive. In this study, we demonstrate that CC domain name is the signaling domain name for inducing cell death for PM-localized NLR Tm-22. Further, we report that nucleotide-binding (NB-ARC) domain name is important for Tm-22 self-association and regulates activation of CC.<\/p>\n","protected":false},"excerpt":{"rendered":"

\ufeffThe error bar indicates the standard deviation from 3 technical repetitions. three times with similar results.(TIF) ppat.1008475.s002.tif (2.1M) GUID:?E0985CE3-FC95-427E-94CA-FC6943BB8976 S2 Fig: Self-association of Tm-22 domains. Fusion proteins with C-terminally HA or Myc tag were used to perform co-IP assays. All samples were subjected to IP with anti-Myc beads. (A) Tm-22 Continue Reading<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-796","post","type-post","status-publish","format-standard","hentry","category-ligand-gated-ion-channels"],"yoast_head":"\n\ufeffThe error bar indicates the standard deviation from 3 technical repetitions - JAK2 inhibitor against human prostate cancer cells<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eurosoi.org\/?p=796\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\ufeffThe error bar indicates the standard deviation from 3 technical repetitions - JAK2 inhibitor against human prostate cancer cells\" \/>\n<meta property=\"og:description\" content=\"\ufeffThe error bar indicates the standard deviation from 3 technical repetitions. three times with similar results.(TIF) ppat.1008475.s002.tif (2.1M) GUID:?E0985CE3-FC95-427E-94CA-FC6943BB8976 S2 Fig: Self-association of Tm-22 domains. Fusion proteins with C-terminally HA or Myc tag were used to perform co-IP assays. All samples were subjected to IP with anti-Myc beads. (A) Tm-22 Continue Reading\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eurosoi.org\/?p=796\" \/>\n<meta property=\"og:site_name\" content=\"JAK2 inhibitor against human prostate cancer cells\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-22T18:53:50+00:00\" \/>\n<meta name=\"author\" content=\"info\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"info\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=796#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=796\"},\"author\":{\"name\":\"info\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#\\\/schema\\\/person\\\/ba68ae543ef2903c0b995cd8992cedfd\"},\"headline\":\"\ufeffThe error bar indicates the standard deviation from 3 technical repetitions\",\"datePublished\":\"2024-10-22T18:53:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=796\"},\"wordCount\":874,\"articleSection\":[\"Ligand-gated Ion Channels\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=796\",\"url\":\"https:\\\/\\\/eurosoi.org\\\/?p=796\",\"name\":\"\ufeffThe error bar indicates the standard deviation from 3 technical repetitions - JAK2 inhibitor against human prostate cancer cells\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#website\"},\"datePublished\":\"2024-10-22T18:53:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#\\\/schema\\\/person\\\/ba68ae543ef2903c0b995cd8992cedfd\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=796#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eurosoi.org\\\/?p=796\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=796#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eurosoi.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\ufeffThe error bar indicates the standard deviation from 3 technical repetitions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#website\",\"url\":\"https:\\\/\\\/eurosoi.org\\\/\",\"name\":\"JAK2 inhibitor against human prostate cancer cells\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eurosoi.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#\\\/schema\\\/person\\\/ba68ae543ef2903c0b995cd8992cedfd\",\"name\":\"info\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g\",\"caption\":\"info\"},\"sameAs\":[\"http:\\\/\\\/eurosoi.org\"],\"url\":\"https:\\\/\\\/eurosoi.org\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\ufeffThe error bar indicates the standard deviation from 3 technical repetitions - JAK2 inhibitor against human prostate cancer cells","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eurosoi.org\/?p=796","og_locale":"en_US","og_type":"article","og_title":"\ufeffThe error bar indicates the standard deviation from 3 technical repetitions - JAK2 inhibitor against human prostate cancer cells","og_description":"\ufeffThe error bar indicates the standard deviation from 3 technical repetitions. three times with similar results.(TIF) ppat.1008475.s002.tif (2.1M) GUID:?E0985CE3-FC95-427E-94CA-FC6943BB8976 S2 Fig: Self-association of Tm-22 domains. Fusion proteins with C-terminally HA or Myc tag were used to perform co-IP assays. All samples were subjected to IP with anti-Myc beads. (A) Tm-22 Continue Reading","og_url":"https:\/\/eurosoi.org\/?p=796","og_site_name":"JAK2 inhibitor against human prostate cancer cells","article_published_time":"2024-10-22T18:53:50+00:00","author":"info","twitter_card":"summary_large_image","twitter_misc":{"Written by":"info","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eurosoi.org\/?p=796#article","isPartOf":{"@id":"https:\/\/eurosoi.org\/?p=796"},"author":{"name":"info","@id":"https:\/\/eurosoi.org\/#\/schema\/person\/ba68ae543ef2903c0b995cd8992cedfd"},"headline":"\ufeffThe error bar indicates the standard deviation from 3 technical repetitions","datePublished":"2024-10-22T18:53:50+00:00","mainEntityOfPage":{"@id":"https:\/\/eurosoi.org\/?p=796"},"wordCount":874,"articleSection":["Ligand-gated Ion Channels"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/eurosoi.org\/?p=796","url":"https:\/\/eurosoi.org\/?p=796","name":"\ufeffThe error bar indicates the standard deviation from 3 technical repetitions - JAK2 inhibitor against human prostate cancer cells","isPartOf":{"@id":"https:\/\/eurosoi.org\/#website"},"datePublished":"2024-10-22T18:53:50+00:00","author":{"@id":"https:\/\/eurosoi.org\/#\/schema\/person\/ba68ae543ef2903c0b995cd8992cedfd"},"breadcrumb":{"@id":"https:\/\/eurosoi.org\/?p=796#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eurosoi.org\/?p=796"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/eurosoi.org\/?p=796#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eurosoi.org\/"},{"@type":"ListItem","position":2,"name":"\ufeffThe error bar indicates the standard deviation from 3 technical repetitions"}]},{"@type":"WebSite","@id":"https:\/\/eurosoi.org\/#website","url":"https:\/\/eurosoi.org\/","name":"JAK2 inhibitor against human prostate cancer cells","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eurosoi.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/eurosoi.org\/#\/schema\/person\/ba68ae543ef2903c0b995cd8992cedfd","name":"info","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g","caption":"info"},"sameAs":["http:\/\/eurosoi.org"],"url":"https:\/\/eurosoi.org\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts\/796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=796"}],"version-history":[{"count":1,"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts\/796\/revisions"}],"predecessor-version":[{"id":797,"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts\/796\/revisions\/797"}],"wp:attachment":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=796"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=796"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}